Retroviral Gag and Env glycoproteins (GPs) are expressed from distinct cellular areas and need to encounter to interact and assemble infectious particles. Retroviral particles may also incorporate GPs derived from other enveloped viruses via active or passive mechanisms, a process known as "pseudotyping." To further understand the mechanisms of pseudotyping, we have investigated the capacity of murine leukemia virus (MLV) or lentivirus core particles to recruit GPs derived from different virus families: the G protein of vesicular stomatitis virus (VSV-G), the hemagglutinin from an influenza virus, the E1E2 glycoproteins of hepatitis C virus (HCV-E1E2), and the retroviral Env glycoproteins of MLV and RD114 cat endogenous virus. The parameters that influenced the incorporation of viral GPs onto retroviral core particles were (i) the intrinsic cell localization properties of both viral GP and retroviral core proteins, (ii) the ability of the viral GP to interact with the retroviral core, and (iii) the expression of the lentiviral Nef protein. Whereas the hemagglutinin and VSV-G glycoproteins were recruited by MLV and lentivirus core proteins at the cell surface, the HCV and MLV GPs were most likely recruited in late endosomes. In addition, whereas these glycoproteins could be passively incorporated on either retrovirus type, the MLV GP was also actively recruited by MLV core proteins, which, through interactions with the cytoplasmic tail of the latter GP, induced its localization to late endosomal vesicles. Finally, the expression of Nef proteins specifically enhanced the incorporation of the retroviral GPs by increasing their localization in late endosomes.
core proteins (Gag), and genomic RNAs that are expressed from distinct cellular areas but need to encounter to interact and assemble infectious particles. The Env GPs are synthesized in the endoplasmic reticulum, whereas Gag proteins are synthesized by ribosomes of the cytosol. The intracellular trafficking of Gag proteins and Env GPs modulates their ability to encounter each other. The viral assembly process has long been thought to occur exclusively at the plasma membrane. However, it is becoming clear that the retroviral assembly and budding sites depend on the type of producer cell. Indeed, in T lymphocytes, assembly of human immunodeficiency virus (HIV) and viral budding is thought to occur at the plasma membrane (1, 2) , whereas in macrophages, these events may occur intracellularly, into multivesicular bodies (MVBs) (3) (4) (5) (6) (7) (8) . Recent studies suggest that the lipid composition of intracellular versus plasma membranes is critical for the targeting of Gag to either site (9, 10) .
During the assembly process, retroviral particles incorporate both viral and cellular proteins via active or passive mechanisms. The relative abundance of some cellular proteins in viral particles and in intracellular and plasma membranes has been compared. Some proteins are enriched in viral particles (or actively included), diluted (or excluded), or constant (or passively incorporated) (5, 6, 11, 12) . Passive incorporation of membrane proteins onto budding viral particles occurs in the absence of specific interactions with the viral core proteins, provided they are present at the budding site and are not sterically incompatible with the viral core. In contrast, active incorporation may require interactions between the Env GP and the viral Gag proteins. These interactions can be direct or indirect, via a cellular factor. Early evidence for Gag/Env interactions indicated that whereas Gag buds from any pole of polarized cells in the absence of Env GP, budding is relocated to the basolateral side upon co-expression with basolateral-located Env GP (13, 14) . Other evidence further support Gag/Env interactions, at least for lentiviruses and onco-retroviruses (15) (16) (17) (18) (19) (20) . Some motifs implicated in Gag/Env interactions have been identified for HIV-1 Env GP and reside in the ␣-helix 2 of the gp41 cytoplasmic tail (16) .
Retroviral particles harboring GPs derived from heterologous enveloped viruses are called "pseudotypes" and are particularly useful to optimize gene transfer into specific cell types (for a review, see Ref. 21 ). However, the co-expression of retroviral cores proteins and heterologous GPs does not necessarily lead to highly infectious particles, and restrictions in pseudotype formation have been reported (22) (23) (24) (25) (26) . The Gag/GP combinations that lead to assembly of retroviral pseudotypes are rather unpredictable, in large part because of our insufficient knowledge of the mechanisms that dictate the assembly and budding of retroviral particles.
To further understand the mechanisms of pseudotype formation, here we have investigated the recruitment by murine leukemia virus (MLV) or simian immunodeficiency virus (SIV) core particles of envelope glycoproteins derived from different virus families: the G protein of vesicular stomatitis virus (VSV-G), the hemagglutinin (HA) from an influenza virus-fowl plague virus (FPV-HA), the E1E2 glycoproteins of hepatitis C virus (HCV-E1E2), and the retroviral Env glycoproteins of MLV or of the RD114 cat endogenous virus. Through a combination of infection assays, biochemical methods, and confocal microscopy, we have determined some viral and cellular parameters that influenced the incorporation of viral GPs onto retroviral core particles. Our results point to distinct mechanisms operating during pseudotype formation: (i) the intrinsic cell localization properties of both viral GP and retroviral core proteins, (ii) the ability of the viral GP to interact with the retroviral core, and (iii) the expression of the lentiviral Nef protein.
EXPERIMENTAL PROCEDURES
Cells-The 293T human embryo kidney (ATCC CRL-1573), the COS-7 African green monkey kidney (ATCC CRL-1651), the TE671 human rhabdomyosarcoma (ATCC CRL-8805), and the Huh-7 hepatocellular carcinoma (27) cells were grown in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum and antibiotics. 293T cells and COS-7 cells were used as producer cells for the assembly of pseudotyped viral particles (19) . TE671 cells and Huh-7 cells were used as target cells for infection assays (19, 25, 28) .
Viral Glycoprotein Expression Constructs-The phCMV-G plasmid, encoding the VSV-G protein (29) , was used as an expression vector construct for the surface glycoproteins derived from the RD114 cat endogenous virus (GenBank accession X87829) (30) , the 4070A strain of amphotropic MLV (31) , an HCV of genotype 1a (28) , and the influenza H7 strain (HA) (25) . The phCMV-RD114 and phCMV-4070A expression vectors, expressing the RD114 and MLV virus envelope glycoproteins, were further modified to generate chimeric glycoproteins that harbor the cytoplasmic tails of the MLV and RD114 glycoproteins, respectively. The resulting chimeric glycoproteins were called RD/TR MLV (19) and MLV/TR RD ( Fig. 1 ) (details of cloning strategy and sequences of oligonucleotides are available upon request). The Nef gene of SIVmac251 was cloned into the pSI expression vector.
Production of Virions-The production of a pseudotyped SIV-based vector was described in a previous report (25) . Briefly, 293T cells plated in 10-cm diameter plates were transfected by 8.1 g of the pR4SA green fluorescent protein (GFP) vector construct (32), 8.1 g of the pSIV-3 ϩ packaging construct (33) , and 2.7 g of the construct expressing the viral glycoprotein. Pseudotyped MLV-derived vectors were generated in a similar manner by DNA transfection of the pTG5349 MLV packaging construct (33) , the pTG13077 MLV GFP vector construct (33) , and the glycoprotein-expressing construct. A calcium-phosphate transfection kit (Clontech) was used according to the manufacturer's instructions. The medium (8 ml/plate) was replaced 16 h after transfection, and the supernatant was harvested 24 h later and filtered through 0.45-m pore size membranes. COS-7 cells were transfected with FuGENE 6 according to the manufacturer's instructions (Roche Diagnosis).
Infection Assays-To determine the infectious virus titers of the different pseudotyped vectors, serial dilutions of vector preparations were added to 2.5 ϫ 10 5 target cells in the presence of 8 g of Polybrene/ml for 4 h at 37°C. The medium was then replaced with normal culture medium for 72 h at 37°C. The transduction efficiency, determined as the percentage of GFP-positive cells, was then measured by fluorescence-activated cell sorter analysis, as previously described (25) . The infectious titers, provided as infectious units (i.u.)/ml, were calculated by using the formula: Titer ϭ %inf ϫ (2.5 ϫ 10 5 /100) ϫ d, where "d" is the dilution factor of the viral supernatant and "%inf " is the percentage of GFP-positive cells as determined by fluorescence-activated cell sorter analysis using dilutions of the viral supernatant that transduce between 5 and 10% of GFP-positive cells.
Antibodies-The RD114 SU goat antiserum (ViroMed Biosafety Labs) raised against the RD114 gp70 envelope surface protein (SU) and the RD114 TM (transmembrane protein) rabbit antiserum (Eurogentec, Seraing, Belgium) were used, respectively, at 1/5,000 and 1/500 dilution for Western blotting. The gp70 Rausher leukemia virus goat antiserum (ViroMed Biosafety Labs) and the 42/114 rat monoclonal antibody (kind gift of A. Pinter) were used at 1/2,000 and 1/2 dilutions to detect the SU and TM proteins of MLV by Western blotting. The 83A25 rat monoclonal antibody (kind gift of L. Evans), directed against MLV SU, was used in immunofluorescence (IF) studies at 1/500. The FPV-HA Kp/Ro rabbit antiserum (kind gift of W. Garten) was used diluted at 1/500 to visualize the different forms of HA glycoprotein. The P5D4 monoclonal antibody (Sigma), directed against VSV-G, was used diluted 1/10,000 for Western blotting and 1/2,000 for IF experiments. The HCV-E2 glycoproteins were detected with the H52 mouse monoclonal antibody at 1/1,000 for Western blotting and with undiluted supernatants of the H53 hybridoma for IF studies (34) . The 2F12 mouse monoclonal antibody, directed against the SIV capsid (CA) protein (National Institutes of Health AIDS Research and Reference Reagent Program), was used at a 1/500 dilution for Western blotting. A mouse antiserum against the SIV matrix (MA) protein (National Institutes of Health AIDS Research and Reference Reagent Program) was used at 1/1,000 dilution to visualize SIV Gag IF studies. The Rausher leukemia virus CA goat antiserum (ViroMed Biosafety Labs) and rabbit antiserum (kind gift of A. Rein) were both used at 1/10,000 dilution for Western blotting IF studies.
Detection of Viral Glycoproteins-Forty hours post-transfection, virus producer cells were chilled on ice, washed twice with cold phosphate-buffered saline 2ϩ (PBS 2ϩ ) (PBS, pH 8.0, supplemented with 0.7 mM CaCl 2 and 0.25 mM MgSO 4 ) and incubated with 0.5 mg/ml of sulfo-NHS-LC-LC-biotin (Pierce) for 30 min at 4°C. Biotinylation was stopped by incubating the cells with 1 M glycine in PBS 2ϩ for 5 min at 4°C. The cells were then washed with PBS, 0.1 M glycine, lysed with MacDougal buffer (20 mM Tris-HCl, pH 8.0, 120 mM NaCl, 200 M EGTA, 0.2 M NaF, 0.2% sodium deoxycholate, 0.5% Nonidet P-40) containing a protease inhibitor mixture (Complete Mini; Roche Diagnostic) and 0.1 M glycine, and centrifuged at 13,000 ϫ g for 30 min; 80% of the cell lysates were incubated overnight at 4°C with streptavidinSepharose beads (Pierce). The beads were then washed with MacDougal glycine buffer, resuspended in a denaturing buffer (1% ␤-mercaptoethanol, 0.5% SDS), and boiled for 5 min. This fraction allowed the detection of cell surface-expressed proteins. The remaining 20% suspension was used to detect the total proteins in crude cell lysates.
Purified virion samples were obtained by ultracentrifugation of viral supernatants through a 1.5-ml 20% sucrose cushion in a Beckman SW41 rotor (25,000 rpm, 2.5 h, 4°C) and suspended in PBS. All samples were mixed 5/1 (v/v) in a loading buffer (375 mM Tris-HCl (pH 6.8) containing 6% SDS, 30% ␤-mercaptoethanol, 10% glycerol, and 0.06% bromphenol blue), boiled for 5 min, and then run on SDS-10% polyacrylamide gel electrophoresis.
Western blotting was performed using standard procedures. 4 Cl, and permeabilized by 0.2% Triton X-100 for 8 min. The fixed cells were incubated for 1 h with the primary antibody in 1% bovine serum albumin/PBS, washed, and stained for 1 h with the corresponding fluorescent Alexa-conjugated secondary antibody (at 0.5 g/ml) in 1% bovine serum albumin/PBS. The cells were then washed several times with PBS and mounted on microscope slides with the antifading agent Prolong (Molecular Probes) prior to image acquisition. Images were acquired with an LSM 510 confocal microscope equipped with an Axiovert 100M microscope (Carl Zeiss Inc., Thornwood, NY) and a 63 ϫ 1.3 numerical aperture Apocromat objective. Alexa 488 was excited with an argon laser line at 488 nm, and emissions were collected with a band pass filter (BP505-550). Alexa 546 or 555 were excited, independently of Alexa 488, with an HeNe laser line at 543 nm, and emissions were collected with a long-pass filter (LP560). The secondary antibodies for Alexa were purchased from Molecular Probes, Inc. Expression vectors encoding specific endosomal marker proteins, cellubrevin-GFP and TI-VAMP-GFP (35) (kind gifts from T. Galli), were cotransfected with GP and Gag vectors.
RESULTS

Retroviral Cores Are Efficiently Pseudotyped by Several Heterologous
GPs-We studied the surface GP derived from several enveloped viruses ( Fig. 1) for their ability to pseudotype MLV core particles: the VSV-G, FPV-HA, HCV-E1E2, and the retroviral Env glycoproteins from the amphotropic MLV or, as control, of the cat endogenous virus RD114 (19) . The infectivity of pseudotyped viral particles harboring a GFP marker gene was determined on appropriate target cells, depending on the cell surface receptors required for cell entry by each vector pseudotype (25, 28) . As reported previously, the infectious titers of the pseudotyped vectors varied greatly, depending on the type of glycoprotein, and ranged between 1 ϫ 10 4 and 1 ϫ 10 7 i.u./ml as determined on the most permissive target cells (Fig. 2B) . Such variations of the infectious titers could be dependent on several cellular factors such as receptor density, receptor binding, and cell entry route of the virions as well as the inherent pseudotyping capacity of the glycoproteins. However, following a screening of a wide array of cell lines and primary cells, we could not identify alternative cell types that were more susceptible to infection than the indicator cells displayed in Fig. 2 (data not shown and discussed in Refs. 25 and 28) . Finally, similar relative differences of infectivity were detected for retroviral pseudotypes produced from either 293T versus COS-7 cells, although the infectious titers were generally lower for viral particles assembled in the latter cells (data not shown and Fig. 2) . Thus, the levels of infectivity reported here reflected the intrinsic functionality of either heterologous glycoprotein upon loading on MLV core particles.
In a previous report (19) , we found that the RD114 Env GP is not readily incorporated on lentiviral core particles, whereas a RD114 Env GP mutant harboring the cytoplasmic tail (cyt) of the MLV Env GP (RD/TR MLV chimera) restored incorporation and infectivity of pseudotyped lentiviral core particles (Fig. 2) . Thus, to further investigate the potential role of the cyt of GPs in retroviral pseudotyping, we constructed a cytoplasmic tail mutant of the MLV Env GP harboring the cyt of the RD114 Env GP (MLV/TR RD Env chimera; Fig. 1 ). We then compared the capacity of all retroviral and non-retroviral GPs to pseudotype either MLV or SIV core particle (Fig. 2, A and B) . We did not observe significant differences in the capacity of the GPs to pseudotype either retroviral core, except for the MLV/TR RD and RD114 Env glycoproteins. Indeed, whereas the MLV/TR RD and RD114 GPs could efficiently pseudotype MLV particles, reaching infectious titers over 2 ϫ 10 6 i.u./ ml, they were poorly assembled on SIV cores, resulting in titers of up to 3 ϫ 10 4 i.u./ml with the latter core particles. This extended our previous results (19) that suggested that the cytoplasmic tail of the MLV Env GP promotes efficient glycoprotein incorporation on lentiviral core particles as compared with that of the RD114 Env GP. Again, the same relative differences of infectivity were detected between pseudotyped SIV viral particles produced in either 293T or COS-7 cells (data not shown and see Figs. 9 versus 2). Altogether, these data indicated that both the type of retroviral core and glycoprotein influenced pseudotype formation. Because the cyt modulates both intracellular localization (19, 65, 66) and pseudotyping properties (Fig. 2 ) of a glycoprotein, we further investigated the cellular pathways of GP recruitment by onco-retroviral and lentiviral Gag proteins, by means of biochemical and confocal microscopy analyses.
Variable Incorporation of Pseudotyping GPs on Viral Particles-We then characterized the expression of Gag proteins and envelope GPs by Western blot analysis of purified virions, crude cell lysates, and biotinylated cell surfaces of virion-producer cells ( Fig. 3 and Table 1 ). The analysis of the GP levels in these different compartments raised different interesting observations. First, we noticed that the efficiency of virion release was independent of the type of pseudotyping GP. Indeed, the ratios of Gag signals detected in purified viral particles versus in total lysates of producer cells did not vary, whatever the GP ( Second, we found that the incorporation levels of the GPs onto viral particles seemed to correlate with the infectious titers. Indeed, despite the lack of an antibody common to all GP that would allow a direct comparison, we estimated the relative levels of GP incorporation on virions by comparing the ratios of GP signals detected in purified viral particles (GP V ) versus in total lysates of virion producer cells (GP L ) ( Fig.  3 and Table 1 ). No significant differences of these ratios were noticed for the MLV Env, FPV-HA, and VSV-G GPs, whatever the type of viral core, because the GP V /GP L ratios were in the range of 200 -300% (Table 1) . These results were in agreement to the maximal infectious titers of the resulting pseudotyped virions that ranged between 10 6 and 10 7 i.u./ml (Fig. 2) . Compared with these latter glycoproteins, and despite strong expression levels in producer cells, the HCV GPs were less efficiently incorporated on viral particles irrespective of the viral core type (Fig. 3) , with GP V /GP L ratios in the range of 10 -15% (Table 1) , consistent with poorer infectious titers (Fig. 2) . Finally, despite expression levels in producer cell lysates similar to those of MLV Env GP (Fig. 3 , compare lanes oЈ versus lЈ and o versus l), the MLV/TR RD GP was poorly incorporated onto SIV core particles as compared with the MLV Env GP (Fig. 3A , compare lanes m versus j and mЈ versus jЈ; Table 1 ), as detected using the same antibody. This was consistent with the 40 -50-fold difference of infectivity between virions pseudotyped with either GP (Fig. 2) .
Third, we found that the viral incorporation of some retroviral GPs was strongly influenced by the type of core particle. Indeed, whereas the MLV/TR RD and RD114 GPs were efficiently recruited by MLV core particles, in agreement with the high infectious titers of the resulting viral particles (Fig. 2) , they could poorly pseudotype SIV core particles (compare SU and TM protein levels in lanes m versus mЈ of Fig. 3 for MLV/TR RD GP and in Ref. 19 for RD114 GP; Table 1 , GP V /GP L ratios of 200 and 15% for the MLV/TR RD GP on MLV and SIV particles, respectively). This difference of GP incorporation levels between MLV and SIV core particles was not because of a difference of budding/release of either virion type because similar levels of viral incorporation were noticed for the other glycoproteins, i.e. FPV-HA, VSV-G, HCV-E2, and MLV Env (Fig. 3, compare lanes a, d, g, j versus aЈ, dЈ, gЈ, jЈ) . Thus, these results expanded our previous results (19) forms were detected for most glycoproteins and the ratios of these forms for each GP varied in the different compartments analyzed (i.e. purified viral particles (GP V ), cell surface (GP S ), and lysates of virion producer cells (GP L )). The analysis of the variations of these ratios raised several points.
Relative to total cell expression, the VSV-G and FPV-HA GPs, which were efficiently incorporated on virions, were abundantly expressed at the cell surface (Table 1 , GP S /GP L ratios over 200% and Fig. 3, compare  lanes b versus c and a; e versus f and d, respectively) . Furthermore, the The parentheses display the signal intensities of the different forms detected for some glycoproteins, as detailed in the text. c A myristoylation-defective MLV G2A-Gag mutant (19) , unable to bind cell membrane and form viral particles, was expressed with the indicated GPs. . The viral proteins were revealed with appropriate antibodies against the GP or Gag capsid proteins (CA). Several forms could be detected for most GPs. FPV-HA was synthesized as HA 0 precursor proteins that were cleaved by cellular furins into HA 1 and HA 2 GPs (HA 2 was not revealed in these blots). MLV and MLV/TR RD Env GPs were synthesized as immature precursor proteins (Pr) that were further cleaved into mature surface (SU) and transmembrane (TM) subunits. Several glycosylated forms were revealed for HCV-E2. Deglycosylation of the samples by PNGase F treatment raised a single band of about 40 kDa (76) . Scanning of Western blot membranes was performed with the Storm 860 device and signal densities were calculated with the ImageQuant program. Similar patterns of GP expression and maturation were obtained when using COS-7 as the producer cells (not shown).
FPV-HA GP was detected as an uncleaved HA 0 precursor and a mature, cleaved, HA 1 GP. The ratios of either form detected in purified virions versus at the cell surface were similar (Fig. 3, lanes a versus b; aЈ versus bЈ; Table 1 , see HA 0 /HA 1 ratios in parentheses). In contrast, lower HA 1 levels in the HA 1 /HA 0 ratios were detected in cell lysates as compared with those determined at the cell surface or in purified virions (Fig. 3,  lanes a versus c; aЈ versus cЈ; Table 1 ). This suggested that recruitment of FPV-HA GP by retroviral Gag proteins occurs at the cell surface, a possibility that was corroborated by in situ analysis using confocal microscopy (see below).
In contrast to VSV-G and FPV-HA, the HCV GPs were poorly detected at the cell surface as compared with their expression in lysates of producer cells (Fig. 3, compare e.g. lanes h/i (HCV-E2 ) versus e/f (VSV-G) versus b/c (FPV-HA); Table 1 , GP S /GP L ratios of Ͻ20, Ͼ225, and Ͼ250%, respectively). Moreover, the HCV-E2 protein was detected as a fully glycosylated and heterogeneous form on viral particles, whereas its cell surface-associated form was mostly expressed as a poorly glycosylated form (Fig. 3, compare lanes g versus h; gЈ versus hЈ and iЈ). This suggested that the HCV GPs are not recruited at the cell surface by retroviral core proteins, but rather in some intracellular compartments where fully glycosylated HCV GPs may accumulate, as confirmed below by confocal microscopy analysis.
A similar deduction was inferred for the MLV and MLV/TR RD Env glycoproteins. Indeed, only mature GP forms (i.e. SU and TM) were found on MLV and SIV virions despite an abundant expression of both mature SU and precursor (Pr) GPs at the surface of producer cells (Fig.  3 , compare lanes m versus n; mЈ versus nЈ; j versus k; jЈ versus kЈ and see the difference of Pr/SU ratios in Table 1 (in parentheses)). That only mature SU and no Pr forms were incorporated on viral particles was confirmed by enhancing the separation between either protein after removal of N-linked carbohydrates by PNGase F treatment or on gels of greater resolution (data not shown). Furthermore, we found that both the cyt and retroviral core types influenced the maturation of the MLV and MLV/TR RD Env glycoproteins, as deduced from the Western blot Depending on the focal plan of the observation, the nucleus will then appear as "empty" or "full" of GP.
analysis of the total lysates and the surface of the producer cells. First, in either compartment, whereas only a small fraction of Env Pr could be detected for the MLV Env GP co-expressed with SIV Gag proteins ( versus n and o) . Second, the maturation of the MLV Env GP was significantly augmented in either compartment upon co-expression with MLV Gag proteins (Fig. 3B) as compared with when these GPs were expressed alone (Fig. 3C ) or co-expressed with SIV Gag proteins (Fig. 3A) . Whereas the Pr/SU ratio in cell lysates was 15/85 upon co-expression with SIV Gag proteins or without co-expressed Gag proteins, this ratio was changed to 55/45 for MLV Env GP co-expressed with MLV Gag proteins ( Table 1 , Pr/SU ratios in parentheses; Fig. 3 , compare lanes l and r versus lЈ). This alteration of GP processing was specifically because of the expression of membranebound MLV Gag proteins because the Pr/SU ratio was identical whether the MLV Env glycoproteins were expressed alone (Fig. 3C) or co-expressed with either SIV Gag proteins (Fig. 3A) or myristoylationdefective MLV Gag proteins, which prevent Gag attachment to cell membranes ( Fig. 3D ) ( Table 1 , compare Pr/SU ratios in parentheses). This suggested the possibility of an interaction, of direct or indirect nature, between MLV Env GP and MLV Gag proteins bound to membranes. Altogether, these results extended our previous findings obtained with the RD114 GP (19) that indicated that the MLV Env cyt promotes more efficient GP maturation than that of RD114 Env GP and that MLV Gag influences GP processing and localization. The Viral GP Determines the Site of Gag/GP Co-localization-To investigate the site of viral assembly, we analyzed the cellular localization of GP and Gag by confocal microscopy. Protein markers were used to identify the different intracellular compartments where the viral components localize (19) : TI-VAMP for late endosomes and MVBs (35) , cellubrevin for recycling endosomes (36) , and calreticulin for the endoplasmic reticulum (ER) (37) . Expression of SIV and MLV Gag proteins was detected as punctuate patterns, dispersed underneath the plasma membrane (green arrows) and throughout the cell cytoplasm (Fig. 4A) , as previously described (7, 8) , hence suggesting The different GPs were abundantly expressed in the ER and/or in the Golgi apparatus, consistent with their synthesis through the secretory pathways, yet they also exhibited additional cellular localizations (Fig.  4B) . Indeed, the FPV-HA and VSV-G glycoproteins were readily detected at the cell surface (Fig. 4B, red arrows in panels a and b) , in agreement with the results of immunoblots (Fig. 3) , and, for FPV-HA, in some intracellular vesicles. Interestingly, whereas co-expression with either MLV or SIV Gag proteins was not found to influence the localization of FPV-HA and VSV-G (compare Fig. 4B versus Fig. 5, A and B) , the localization of the MLV and SIV Gag proteins at the plasma membrane was reinforced upon co-expression with either glycoprotein, as detected by patches of continuous staining lining the cell surface (compare Fig. 4A versus Fig. 5, green arrows in panels a, b, aЈ, and bЈ) . Intensive co-localization of Gag proteins with the FPV-HA and VSV-G glycoproteins was detected at these cellular locations (Fig. 5, yellow arrows  in panels a, b, aЈ, and bЈ) . Thus, these results suggested that the distribution of the MLV or SIV Gag proteins was altered upon FPV-HA or VSV-G expression and corroborated the notion of immunoblot analysis (Fig. 3) that the plasma membrane was the cellular site where the glycoproteins are recruited during envelope assembly of these viral pseudotypes.
In contrast to VSV-G and FPV-HA, the HCV, MLV, and MLV/TR RD glycoproteins were not detected at the cell surface (Figs. 4 and 5 , see the outlines of the cell surface as white lines in panels c, d, e, cЈ, dЈ, and eЈ), consistent with the results of immunoblots that indicated poorer expression at this site (Fig. 3) . However, the MLV Env GP was frequently detected in endosomal vesicles (Figs. 4 and 5, red arrows in panels d and dЈ), as shown by using specific protein markers (Fig. 6 and data not shown). Likewise, MLV or SIV Gag proteins could not or could hardly be detected under the plasma membrane upon co-expression with the MLV glycoprotein (Fig. 4A versus Fig. 5 , A and B, panels d and dЈ: see the outline of the cell surface in white lines), but were predominantly localized in endosomal vesicles. A strong co-localization between MLV GP and either SIV or MLV Gag proteins was observed in these vesicles (Fig.  5, A and B, yellow arrows in panels d and dЈ) that were further characterized as late endosomes using a TI-VAMP protein marker (Fig. 6, 
panel b).
This strong GP/Gag co-localization was consistent with the high infectious titers of the resulting retroviral pseudotypes (Fig. 2) . In contrast to the MLV GP, the HCV and MLV/TR RD glycoproteins were rarely detected in vesicles of the endocytic pathway (Fig. 4B , red arrows in panels c and e) and were predominantly found in the ER. Such a localization pattern was unchanged whether these glycoproteins were expressed alone (Fig. 4B) or co-expressed in the presence of SIV Gag proteins (Fig. 5A) . Co-localization of the HCV GPs with SIV or MLV Gag proteins could not be detected in the ER but exclusively in the few endosomal vesicles where these glycoproteins were also found (Fig. 5, A and B, yellow arrows in panels c and cЈ), which were further identified as late endosomes (Fig. 6, panel a) . Likewise, co-localization between the SIV Gag proteins and the MLV/TR RD GPs was only observed in the rare endosomal vesicles where this GP was detected (Fig. 5A , yellow arrow in panel e). Altogether, the low level of co-localization in late endosomes of retroviral Gag with HCV GP and of lentiviral Gag with MLV/TR RD GP seemed in good agreement with the low viral incorporation levels of these glycoproteins (Fig. 3) and with the poor infectious titers of the resulting viral pseudotypes (Fig. 2) .
Interestingly, whereas the MLV/TR RD GP expressed alone (Fig. 4B ) or in the presence of SIV Gag proteins (Fig. 5A ) was poorly detected in endosomal vesicles, its intracellular localization was clearly altered upon co-expression with MLV Gag proteins, leading to frequent detection into endosomal vesicles (Figs. 4 and 5, A versus B, red arrows, compare panels e versus eЈ). Additionally, strong co-localization of this GP with MLV Gag proteins could be observed in such vesicles (Fig. 5B , yellow arrows in panel eЈ) that were further characterized as late endosomes (Fig. 6, panel c) . This indicated that MLV Gag proteins could specifically, directly or indirectly, interact with the MLV/TR RD GP and induce its intracellular re-localization. This was correlated to the strong increase of incorporation of the MLV/TR RD GP on MLV core particles as compared with SIV core particles (Fig. 3, compare lanes mЈ versus m) and to the increased infectivity of these former pseudotypes as compared with later ones (Fig. 2) .
Altogether, these results pointed to distinct mechanisms operating during pseudotype formation. The first mechanism depends on intrinsic properties of the pseudotyping glycoprotein that dictates the site of co-localization between GP and Gag proteins at the cell surface (i.e. FPV-HA and VSV-G) or, alternatively, in late endosomes (i.e. HCV and MLV GPs). The second mechanism depends on the possibility of interactions between either viral component (i.e. MLV and MLV/TR RD GPs with MLV Gag) that could induce their re-localization in an appropriate assembly compartment (i.e. the late endosome). For either mechanism, the level of co-localization between Gag and GP detected by confocal microscopy was consistent with the level of viral incorporation of the glycoprotein and with the infectious titers of the resulting retroviral pseudotypes.
Nef Selectively Influences Pseudotype Formation with Retroviral GPsThe Nef accessory protein was previously found to influence the infectivity of pseudotyped lentiviruses (38, 39) . To further investigate its influence on pseudotype formation, we compared the expression/assembly of the Gag/GP viral components and the infectivity of lentiviral particles in the presence or absence of SIV Nef proteins. Correct expression of the Nef protein was demonstrated by immunoblotting of cell lysates and confocal microscopy (data not shown).
Interestingly, we detected an increase of GP viral incorporation, ranging from to 2-to 20-fold depending on the type of glycoprotein, when the virions were generated in the presence of Nef proteins ( Fig. 7 ; Table  2 ). This effect was induced, in part, by the 2-fold increase of the expression of Gag proteins and virion release (Fig. 7 , compare lanes g versus h 
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and e versus f; Table 2 ), which appeared to be independent of the GP type. This result was consistent with the notion that the Nef protein acts at different cellular levels to increase the efficiency of the viral assembly process directly via stimulating Gag processing and release (40) or, indirectly, via increasing the biogenesis of viral assembly platforms, such as raft and MVBs (41, 42) . To determine the influence of Nef in specific viral incorporation of the GP, independently of the increase of Gag release, we calculated the GP/Gag ratios using the signals acquired from Western blot analysis (Table 2) . Remarkably, Nef expression selectively modified the viral incorporation of the retroviral glycoproteins (Fig. 7) . Indeed, whereas the GP/Gag ratios detected for the FPV-HA, VSV-G, and HCV GPs were not modified whether or not Nef was expressed (Fig.  7 , for example, compare lanes a versus b or e versus f or i versus j; Table  2 ), Nef expression increased the GP/Gag ratios of the MLV and MLV/ TR RD GPs, as well as of the previously described RD114 and RD/TR MLV GPs (19) , by about 3-10-fold (Fig. 7 , for example, compare lanes eЈ versus fЈ or mЈ versus nЈ; Table 2 ). Additionally, although they were predominantly detected in the ER in the absence of Nef (Fig. 8A, panels a and c) , the MLV/TR RD and RD114 glycoproteins were re-localized in intracellular vesicles upon Nef co-expression (Fig. 8A, red arrows in panels b and d) , which appeared to be late endosomes, as demonstrated using the TI-VAMP marker (Fig. 8B) . Of note, such an alteration of the localization of these retroviral glycoproteins was only achieved via GP/Nef interactions, direct or indirect, and was independent of the presence of lentiviral Gag proteins (data not shown). Furthermore, the late endosomal re-localization of MLV/TR RD and RD114 GPs detected upon Nef expression was associated with co-localization between SIV Gag and either glycoprotein (Fig. 8A, yellow arrows in panels b and d) . No obvious effect of Nef could be detected for the MLV and RD/TR MLV GPs (data not shown) that (Figs. 4-6 and Ref. 19) , perhaps because further accumulation of either GPs that were already efficiently targeted to late endosomal vesicles in the absence of Nef cannot be detected by confocal microscopy. Because we found that the colocalization of retroviral GPs and lentiviral Gag proteins was critical for pseudotype formation (Fig. 5) , these results suggested that the increased viral incorporation of the retroviral GPs ( Fig. 7 and Table  2 ) was because of their Nef-induced augmented accumulation in late endosomes and co-localization with SIV Gag proteins (Fig. 8) . Consistently, the infectivity of lentiviral vectors pseudotyped with the MLV/TR RD and RD114 glycoproteins was increased by up to 12-fold (Fig. 9) , most likely as a result of strongly augmented viral incorporation. The influence of Nef on the infectivity of vectors pseudotyped with the MLV and RD/TR MLV GPs was less marked than for the RD114 and MLV/TR RD glycoproteins (Fig. 9) , despite significant increase of viral incorporation of all these retroviral GPs (Fig. 7) . Perhaps these former GPs were already incorporated in the absence of Nef over a threshold of density sufficient to promote optimal levels of infectivity. Indeed, note that the incorporation levels of the MLV and RD/TR MLV GPs were already high as compared with those of the MLV/TR RD and the RD114 GPs in the absence of Nef (Fig. 7 , panels bЈ versus fЈ and nЈ versus jЈ) and were similar to those of the latter glycoproteins in the presence of Nef (Fig. 7 , panels bЈ versus eЈ a Signal intensities (arbitrary units, normalized to signals detected in the Јno NefЈ condition), acquired from scanning of Western blot membranes (e.g. Fig. 7 ) with a Storm 860 device, are displayed here for the SIV Gag proteins expressed alone and for the indicated glycoproteins co-expressed with SIV core proteins as detected in total cell lysates and purified viral particles. The results are the mean Ϯ S.D. of three experiments. The variation of signals for SIV Gag proteins co-expressed with the different GPs were within the range of those obtained in the absence of GP co-expression (data not shown). b The -fold increase of viral GP/Gag ratios calculated in the presence versus absence of Nef is shown for each pseudotyped SIV particle. GP/Gag ratios were calculated by using the signal intensities of each viral GPs and Gag proteins as detected in purified viral particles. c NA, not applicable. and nЈ versus iЈ). Thus, an increased GP incorporation over a certain threshold may not necessarily result in augmented infectivity, as reported previously for MLV or lentiviral vectors pseudotyped with Eco-, ampho-MLV, or HIV glycoproteins (43) . Altogether, these results indicated that Nef expression optimizes co-localization of retroviral GPs with lentiviral Gag proteins in late endosomes and hence viral incorporation, with a particularly marked effect for those retroviral GPs that inherently do not accumulate in the endosomal pathway.
DISCUSSION
To gain insights in the process of envelope assembly of retroviral pseudotypes, here we have investigated the capacity of envelope GPs derived from different virus families to interact and/or coat onco-retroviral and lentiviral core particles. The parameters that were found to influence the incorporation of viral GPs onto retroviral core particles were (i) the intrinsic cell localization properties of both the viral GP and the retroviral core proteins, (ii) the ability of the viral GP to interact, directly or not, with the retroviral core, and (iii) the expression of the lentiviral Nef protein. These different parameters determined the ability of Gag and GP to co-localize in a common cellular compartment and, ultimately, to lead to assembly of infectious viral particles. Whereas the data reported here were obtained from transiently transfected 293T or COS-7 cells, it is possible that the mechanisms that govern pseudotype formation also operate in envelope assembly of wild-type retroviruses in naturally infected cells.
Envelope Assembly of Pseudotyped Retroviruses Is Determined by GP Localization at the Cell Surface or in Late Endosomes-The assembly of the envelopes of retroviruses and pseudotyped retroviruses, and the subsequent budding of viral particles has long been thought to occur at the plasma membrane of infected cells (44) , a pathway supported by electron microscopy data (reviewed in Refs. 45 and 46) and by plasma membrane co-localization of the two types of viral components in glycolipid-enriched microdomains (47) (48) (49) (50) . In agreement with these previous findings, our results suggest that the VSV-G and FPV-HA GPs were most likely incorporated on retroviral particles from the cell surface. Compared with other GPs such as those derived from HCV and MLV, we found that expression of VSV-G and FPV-HA GPs was strongly enriched at the cell surface and was not affected by co-expression of Gag proteins. Furthermore, co-localization between VSV-G or FPV-HA GPs and Gag proteins was predominantly detected at the cell surface but only poorly into vesicles of the endosomal and secretory pathways. This is consistent with the available evidence from the literature that indicate the efficient export of VSV-G from the endoplasmic reticulum (52) and the association of FPV-HA and VSV-G GPs in raft microdomains of the cell surface (50, 51) . Additionally, the envelope assembly on VSV or FPV virions is thought to occur at the cell surface (53, 54) . Finally, although the VSV-M matrix protein directly interacts with the cytoplasmic tail of VSV-G (55, 56) , the localization of VSV-G into membrane microdomains was reported to occur independently of the homologous viral core components (54) . Altogether, these previous results are congruent with our finding that cell surface localization of VSV-G and FPV-HA GPs was independent of the co-expression of the retroviral core proteins and suggest that the viral incorporation of these GPs on retroviral core particles occurs passively, via concentration of both types of components in coincident cell locations. These considerations are not coherent, however, with the finding that the localization of the Gag proteins under the cell surface seemed intensified upon coexpression with either GP. Indeed, no direct interactions are expected to occur between the retroviral Gag proteins and the cytoplasmic tails of FPV-HA or VSV-G, which are derived from very different viruses.
Results of others have indicated that the modification of the subcellular distribution of the phospholipid phosphatidylinositol (4,5)-bisphosphate (9) and of the essential raft-component cholesterol (57) could influence the targeting of Gag proteins to either the plasma membrane or the MVBs. Thus, one possibility to explain that FPV-HA or VSV-G seem to influence Gag localization is that overexpression of either GP induces a perturbation of the cellular lipids repartition leading to redistribution of Gag proteins and, indirectly, to an efficient co-localization of both GP and Gag proteins.
In contrast to these two GPs, the HCV GPs were predominantly detected in the ER but very poorly at the cell surface. Several studies revealed that the HCV GPs harbor ER retention signals within their transmembrane domains and that no canonical endocytic trafficking signal can be found in their very short cytoplasmic tails (58) . Furthermore, HCV assembly is thought to occur intracellularly, in the ER or into poorly characterized intracellular membranous formations (59 -61) . Additionally, cellular localization and processing of HCV glycoproteins is dependant on the available expression systems (62) . In addition to ER localization, low level cell surface expression (28, 62) , as well as localization of the HCV GPs in endosomal vesicles (Fig. 3) , can also be detected when using appropriate expression systems, in a manner inde-pendent of the co-expression of retroviral core proteins. Finally, colocalization of HCV GPs and retroviral Gag proteins could be detected in late endosomes, but neither at the cell surface nor in the ER.
Altogether, the results obtained with FPV-HA, VSV-G, and HCV GPs suggest that the choice between two possible sites of envelope assembly of retrovirus pseudotypes, i.e. the cell surface versus the late endosome, is largely determined by intrinsic properties of the heterologous viral glycoproteins and that their recruitment on retroviral core particles occurs passively. This is consistent with the current notion that different sites of assembly of retroviral core particles and, potentially, of viral egress, may co-exist and/or depend on the virion producer cell type (63, 64) . In HeLa and T cells, the majority of assembling HIV-1 particles are detected at the plasma membrane. In contrast, results from several groups indicate that the assembly process of MLV and lentiviruses occurred in late endosomes or in MVBs in macrophages, COS and 293T cells (5, 7, 8, 20) , in agreement with this report.
Pseudotype Formation Is Influenced by Interactions between Gag and the Retroviral GP-The mechanisms of recruitment of retroviral assembly of the retroviral envelopes remain poorly characterized. There is evidence that the cytoplasmic tails of the retroviral Env GPs harbor several determinants that allow their trafficking between the secretory vesicles, the cell surface, and the endosomal vesicles (65) (66) (67) (68) (69) and that determine the site of virion budding in polarized cells (13, 70) . The punctuated staining detected for the MLV GP as well as its co-localization with intracellular markers indicates its abundant presence in endosomal vesicles, particularly in late endosomes and MVBs, but a much weaker expression at the plasma membrane that could only be detected using cell surface biotinylation. It is likely that these vesicles are sites where Gag recruits the retroviral Env GPs, at least in 293T and COS-7 cells that were used in this work. Indeed, alterations of the MLV GP cyt, as in the MLV/TR RD chimera, which reduce its accumulation in late endosomes (19) , prevent co-localization with SIV Gag proteins and hence recruitment by lentiviral core particles. This is consistent with our previous findings (19) that introducing in the cyt of an ER-retained retroviral glycoprotein (e.g. the RD114 Env GP) the appropriate motifs that stimulate intracellular trafficking leads to GP re-localization to late endosomes and incorporation on lentivirus particles. Thus, the correlation between co-localization of these different onco-retroviral GPs with SIV Gag proteins in late endosomes and their levels of incorporation onto SIV particles suggested that they are passively recruited during envelope assembly of lentiviral pseudotypes. In contrast, indirect evidence suggested that specific interactions occurred between the cytoplasmic tails of the MLV Gag proteins and the MLV or RD114 GPs. Indeed, in the presence of MLV core proteins, (i) the maturation of both MLV and MLV/TR RD GPs was modified, (ii) the MLV/TR RD GP was re-localized into MVBs, and (iii) the infectious titers of the MLV/TR RD pseudotypes were significantly increased. These results indicated that whereas the cytoplasmic tails of the RD114 and MLV GPs induce differential intracellular traffic and localization, they share conserved determinants mediating direct or indirect interactions with MLV Gag proteins. Such interactions are likely to modify the trafficking pathway of these GPs (71) , perhaps via competition between the MLV Gag proteins and the intracellular trafficking effectors that interact with their cytoplasmic tails. For example, MLV Gag may prevent the interaction of the Env cytoplasmic tail with a cellular factor involved in GP recycling from the endosomal vesicles to the trans Golgi network or the cell surface. This could explain the accumulation of onco-retroviral GPs in late endosomes and their strong co-localization with MLV Gag proteins. Thus, the cytoplasmic tail of a retroviral GP could differentially influence pseudotype formation on onco-retroviral or lentiviral core particles by allowing direct or indirect interactions with Gag proteins, hence providing an active mechanism of envelope assembly (e.g. MLV or RD114 GPs with MLV core proteins) or, in a nonexclusive manner, by allowing concentration of Env GPs at the envelope assembly sites, hence explaining passive mechanism of GP incorporation (e.g. MLV GP with heterologous SIV cores proteins).
Nef Stimulates Pseudotype Formation with Retroviral GPs-Our results indicate that the lentiviral Nef protein selectively stimulates pseudotype formation with retroviral GPs but not with the other GPs. This is partially in agreement with previous reports that indicated that the Nef protein differentially influenced the infectivity of pseudotyped lentiviruses, depending on the cell entry route determined by the pseudotyping GP (38, 39) . These previous studies suggested that Nef acts at a post-entry step of infection and that virions pseudotyped with pH-dependant GPs do not require Nef for optimal infectivity, perhaps because the viral cores of virions pseudotyped with such GPs are directly released into a intracellular compartment that facilitate post-fusion events. Our results extend these findings and confirm that, in contrast to retroviral GPs, the FPV-HA, VSV-G, and HCV GPs, which are pHdependant (72), are not sensitive to Nef. Furthermore, our data suggest that the phenotype of sensitivity to Nef also relies on mechanisms of envelope assembly, thus providing novel insights on how Nef may influence viral infectivity. Indeed, we found that Nef increased endosomal accumulation and viral incorporation of GPs harboring determinants in their cytoplasmic tail that allow intracellular trafficking through the endocytic pathway and whose assembly site are MVBs (i.e. RD114, RD/TR MLV , MLV, and MLV/TR RD Env GPs). This is reminiscent of the pleiotropic effects of Nef on early/recycling endosomal compartments and on protein trafficking within the endosomal system (42, 73, 74) . In contrast, no Nef effect was detected for the GPs recruited at the cell surface (VSV-G and FPV-HA GPs) or that do not harbor in their cytoplasmic tail determinants of endocytic trafficking (HCV GPs). Thus, in addition to a role of Nef at a post-entry stage, our results suggest an additional mechanism to the wide array of activities attributed to Nef and stimulation of infection (75) .
